Biotin or Pyridoxine Versus Combined Regimen in the Treatment of Onychoschizia

February 2025 | Volume 24 | Issue 2 | 174 | Copyright © February 2025


Published online January 24, 2025

doi:10.36849/JDD.7687R1

Avner Shemer MDa,b*, Anna Lyakhovitsky MDa,b*, Vered Hermush MDc,d, Riad Kassem MDa,b, Baruch Kaplan MDe, Eran Galili MDa,b

aDepartment of Dermatology, Sheba Medical Center, Tel HaShomer, Ramat-Gan, Israel
bFaculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel
cDepartment of Geriatrics and Skilled Nursing, Laniado Medical Center, Netanya, Israel
dRuth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
eAdelson School of Medicine, Ariel University, Ariel, Israel

Abstract
Background: Onychoschizia is characterized by distal nail plate splitting. Several therapeutic approaches exist, most of which are based on case reports or small non-comparative case series.
Objective: To evaluate safety and efficacy of oral biotin and pyridoxine for treating onychoschizia.
Patients and Methods: A retrospective comparative study was conducted among patients with idiopathic fingernail onychoschizia. Patients were prescribed 1 mg/day biotin, or 100 mg/day pyridoxine or both, for 3 months. Complete response (improvement of more than 90%) and partial response (improvement of more than 50%) were assessed after 6 to 9 months.
Results: The study included 61 patients with fingernail onychoschizia (mean age 40.5 years [range 20-68 years]). The average number of affected fingernails was 7.0 (±2.0) per patient. The nail condition lasted 11.6 (±4.7) years on average. The combined treatment regimen achieved significantly higher rates of complete response compared to biotin or pyridoxine alone (69.6% vs 10%, 11.1%, respectively;
P values < .001). Partial response (>50% improvement) was achieved in an additional 30.4%, 45%, and 38.9% of patients treated with combined regimen vs biotin or pyridoxine alone, respectively. No adverse events were recorded.
Conclusions: This study demonstrates that the use of biotin and pyridoxine combination is an effective treatment for fingernail onychoschizia.

J Drugs Dermatol. 2025;24(2):174-177. doi:10.36849/JDD.7687R1

INTRODUCTION

Nail plate brittleness is a common condition that primarily affects women over the age of 50 years.1,2 Contact irritant and allergens as well as excessive water exposure are known risk factors, but it can also occur among healthy-term newborns and in women during pregnancy.3,4

Nail brittleness is characterized by nails that split, flake, and crumble, become soft, and lose elasticity. Fingernail fragility is much more common than toenail fragility.2 This condition is mostly idiopathic, but could also be a consequence of various causes, including inflammatory nail disorders, trauma, and systemic diseases.1,2 The main clinical presentations include: onychoschizia, onychorrhexis, and superficial granulation of keratin. Mix presentation could also be seen. Of these, onychoschizia manifests with distal nail plate splitting and is considered to be the most common clinical presentation.1,2

The treatment of nail brittleness primarily aims to reduce the interruption of manual activities as well as improving the aesthetic aspect, as the condition is noticeable. Optimal management requires treatment of the primary cause of brittle nails, when identified. For idiopathic nail brittleness, there are several therapeutic options. All patients should be encouraged to avoid contact irritants and allergens (such as nail polish and detergents), limit exposure to water, and use emollients on a daily basis.2,5 Several studies have found that taking oral supplements, particularly vitamins (including Biotin [vitamin B7], could be beneficial.5–9 These findings, however, are primarily based on non-comparative small case series and case reports. An oral bio-mineral supplement containing amino acids, vitamins (C, E, B6 [pyridoxine], and biotin), and minerals was found to be effective in a single randomized controlled trial of 48 participants.5